Zobrazeno 1 - 4
of 4
pro vyhledávání: '"C. Gilbert Frank"'
Autor:
Charles T. Hankins, Leonard E. Weisman, Howard S. Heiman, K.N. Siva Subramanian, Thomas Rubio, David F. Cruess, C. Gilbert Frank, Thomas J. Kueser, Barbara J. Stoll, Gerald W. Fischer, Val G. Hemming
Publikováno v:
The Journal of pediatrics. 125(6 Pt 1)
To determine whether a single dose of intravenously administered immune globulin (IVIG) decreases late-onset sepsis in premature infants, we prospectively entered 753 neonates with birth weight 500 to 2000 gm, gestationor = 34 weeks, and ageor = 12 h
Autor:
Thomas Rubio, C. Gilbert Frank, Bascom F. Anthony, Howard S. Heiman, Thomas J. Kueser, Barbara J. Stoll, David F. Cruess, Val G. Hemming, Charles T. Hankins, Gerald W. Fischer, Leonard E. Weisman, K.N. Siva Subramanian
Publikováno v:
The Journal of pediatrics. 121(3)
Newborn infants may have IgG deficiencies that increase their susceptibility to bacterial infection. To determine whether intravenous immune globulin (IVIG) therapy improves survival rates in early-onset sepsis, we prospectively entered 753 neonates
Autor:
GLENN D. JORDAN, NICHOLAS J. THEMELIS, SUSAN O. MESSERLY, ROBERT V. JARRETF, JOSE GARCIA, C. GILBERT FRANK
Publikováno v:
Pediatrics. 78:540-541
To the Editor.— Barrington et al1 recently undertook an investigation designed to elucidate the mechanism of action and clinical effects of doxapram in neonates. There is currently considerable interest in the use of this agent as a therapeutic adj
Autor:
GLENN D. JORDAN, NICHOLAS J. THEMELIS, SUSAN O. MESSERLY, ROBERT V. JARRETT, JOSE GARCIA, C. GILBERT FRANK
Publikováno v:
Pediatrics. 79:842-842
In Reply.— The comments of van der Hal et al serve to further underscore our concerns regarding the uncritical appropriation for use in neonates of pharmacologic agents belonging to the "adult" formulary. The issue is pervasive—the overwhelming p